Bryan Gutierrez Email & Phone Number

Cambridge, Massachusetts, United States

Lexington, Massachusetts, United States

Focused on company creation and incubation. Led US operations for Gordian and portfolio companies.

Cambridge, MA

Head of Program and Alliance Management, and Program Team Leader for Casma's first development program.

Lead program manager for early stage development at Agios. Partnered with Program Team Leader in the clinical development of AG-270 (a first-in-class MAT2A inhibitor; Phase 1).

Cambridge, MA

Program manager for early stage development programs in oncology and rare diseases. Partnered with Program Team Leaders in the development of: (1) AG-270 program (a first-in-class MAT2A inhibitor) from discovery to first-in-human studies and (2) AG-946 preclinical program (a next-generation PKR activator).

Cambridge, MA

Responsible for the management and development of Momenta's pre-IND biosimilar programs in partnership with Mylan Pharmaceuticals. Partnered with Program Team Lead in the creation and execution of program work plans, program strategy, budgets, scenario planning, and identification of program goals/milestones.

Cambridge, MA

Managed early stage development for Momenta's biosimilar programs, including Momenta and Baxalta’s biosimilar version of Humira® (Phase 1).

Cambridge, MA

CMC operations lead in Momenta's biosimilar division. Responsible for managing early stage development of biosimilar candidates and preparing candidates for partnering.

Cambridge, MA

Team lead for gene expression efforts. Executed and managed large gene expression and next-generation sequencing efforts to support Momenta's biosimilar and novel drug divisions.

Cambridge, MA

Researcher in the area of biopharmaceuticals. In this role, I applied various molecular biology and data analysis techniques to support cell line development, bioprocess development, and other research efforts in the development of biosimilars and novel drugs.

Boston, MA

Research in the area of cancer systems biology, specifically the characterization and mapping of protein-protein interaction networks ("interactome"). This was achieved through various molecular biology, bioinformatics, and high-throughput approaches.

Master’S Degree, Biotechnology Management

Master's thesis on the development of biopharmaceuticals, particularly biosimilars and their valuations.

Bachelor’S Degree, Exercise And Sports Sciences (Specialization In Exercise Physiology)

Science Coursework: Chemistry, Organic Chemistry, Biology, Cellular and Molecular Biology, Biochemistry, Genetics, Statistics, Physics.